We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Videos

Marching for Science in London content piece image
Video

Marching for Science in London

Hear from the organisers, speakers, and protesters at London's March for Science.
Labtube Meets Steve Bird from Waters at Pittcon 2017 content piece image
Video

Labtube Meets Steve Bird from Waters at Pittcon 2017

We spoke to Steve Bird from Waters at Pittcon 2017.
Labtube Meets Andrew Anderson from ACD/Labs at Pittcon 2017 content piece image
Video

Labtube Meets Andrew Anderson from ACD/Labs at Pittcon 2017

We spoke to Andrew Anderson from ACD Labs at Pittcon 2017.
Here’s How RNA interference Works content piece image
Video

Here’s How RNA interference Works

This animation explains how RNAi works and introduces the two main players: small interfering RNAs (siRNAs) and microRNAs (miRNAs).
BioFlo 120 Bioprocess Control Station content piece image
Video

BioFlo 120 Bioprocess Control Station

Sneak a peek at the new BioFlo 120. No matter if you are working in an academic or industrial research setting, with microbial, mammalian, insect or plant cells, the BioFlo 120 is an attractive bioreactor/fermentor solution to meet your needs. Available soon!
The Brave New World Of Immuno-Oncology content piece image
Video

The Brave New World Of Immuno-Oncology

Essen Bioscience's animation of how scientists harness the body's immune response to fight cancer.
Advanced Targeting with Chimeric Antigen Receptors content piece image
Video

Advanced Targeting with Chimeric Antigen Receptors

Martin Pule, Autolus Ltd discusses Advanced Targeting with Chimeric Antigen Receptors at Antibodies in Drug Discovery 2016.
OptiLinked FDCs: Fully Armed Antibody Fragment Drug Conjugates content piece image
Video

OptiLinked FDCs: Fully Armed Antibody Fragment Drug Conjugates

Mahendra Deonarain, Antikor Biopharma Ltd, UK discusses Fully-Armed Antibody Fragment Drug Conjugates at Antibodies in Drug Discovery 2016.
Discovery and Manufacturing Strategies for Novel, Homogeneous ADC Molecules content piece image
Video

Discovery and Manufacturing Strategies for Novel, Homogeneous ADC Molecules

Several key learnings have emerged through application of rapid re-iterative ADC design using reactive non-natural amino acids to specifically position conjugation sites: Site-specific homogeneous molecules can improve therapeutic index preclinically and have the potential to optimize clinical impact for a given combination of antibody and warhead. Site matters.
Bi-specific Redirected T-cell Immunotherapy Targeting P-cadherin Expressing Tumors content piece image
Video

Bi-specific Redirected T-cell Immunotherapy Targeting P-cadherin Expressing Tumors

Lioudmila Tchistiakova, Senior Director, Pfizer Inc, USA, speaking at Antibodies in Drug Discovery.
Advertisement